Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01076062 · ClinicalTrials.gov registry record · NA

Elective Induction of Nulliparous Labor

A NA study, sponsored by Madigan Army Medical Center.

Completed
Registry status
NA
Development phase
162
Enrollment target

NCT01076062 is a NA study that has completed, run by Madigan Army Medical Center. The registered enrollment target is 162 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01076062, a NA study, has completed, sponsored by Madigan Army Medical Center.

COMPLETED
Registry status
NA
Development phase
162 participants
Enrollment target

Study Summary

Primary outcome: to evaluate the effect of elective induction of labor (IOL), at 39 weeks gestation, on cesarean delivery rates in nulliparous women compared to expectant management (EM). Secondary outcomes: to evaluate differences in the mean number of clinic visits/antepartum tests avoided with IOL, to compare the differences in utilization of inpatient resources (mean duration of inpatient stay, mean duration of labor), and to evaluate the effect of IOL on the risk of urinary/anal incontinence and sexual dysfunction as analyzed using previously validated measurements. We will evaluate differences in the rate of cervical change once active labor is diagnosed, and the time from completion of active labor, defined as complete dilation and complete effacement, to the delivery of fetus (definition of second stage of active labor). Furthermore, other secondary outcomes to be evaluated include comparisons between IOL and EM in regards to the occurence of chorioamnionitis, stillbirth, operative vaginal delivery, and meconium stained amniotic fluid. An evaluation of the predictive value of cervical length and Bishop score for vaginal delivery will also be examined.

Interventions

  • PROCEDURE Induction of Labor

Trial Details

FieldValue
Enrollment Target 162 participants
Start Date 2009-10-27
Est. Completion 2017-04-24
Phase NA

Sponsor

Madigan Army Medical Center

22 total trials

What the Registry Record Tells You About NCT01076062

The ClinicalTrials.gov registry entry for NCT01076062 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 162 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Madigan Army Medical Center, which has 22 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Induction of Labor is the first listed.

NCT01076062 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01076062 about?

NCT01076062 is a clinical study titled "Elective Induction of Nulliparous Labor". Primary outcome: to evaluate the effect of elective induction of labor (IOL), at 39 weeks gestation, on cesarean delivery rates in nulliparous women compared to expectant management (EM). Secondary outcomes: to evaluate differences in the mean number of clinic visits/antepartum tests avoided with I...

What is the current status of trial NCT01076062?

This trial is currently completed. It is a NA study. The enrollment target is 162 participants. The study started on 2009-10-27. Estimated completion is 2017-04-24.

What interventions are being tested in trial NCT01076062?

The interventions under investigation include: Induction of Labor (PROCEDURE).

Who is sponsoring clinical trial NCT01076062?

This trial is sponsored by Madigan Army Medical Center, which has 22 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.